Weidman talks us through the long road to get Symplicity ready to help patients with hypertension
December 1, 2021 • 0 Comment
In this episode, Jason Weidman, SVP and President of Coronary & Renal Denervation at Medtronic, says he’s doing exactly what he set out to do when he became an engineer over 20 years ago, creating lifesaving medical devices. Weidman is leading Medtronic’s push to secure FDA approval for Medtronic Symplicity Spyral™ RDN system, which uses renal denervation to reduce hypertension. Medtronic’s clinical trials of Symplicity have been among the most closely watched – and most difficult to execute – in the industry. Weidman will discuss the challenges while also sharing his reasons for optimism.
Leave A Reply
You must be logged in to post a comment.